...
首页> 外文期刊>African Journal of Biotechnology >Combined effect of vanadium and nickel on lipid peroxidation and selected parameters of antioxidant system in liver and kidney of male rat
【24h】

Combined effect of vanadium and nickel on lipid peroxidation and selected parameters of antioxidant system in liver and kidney of male rat

机译:钒和镍联合作用对雄性大鼠肝肾脂质过氧化和抗氧化系统选择参数的影响

获取原文

摘要

In this investigation, hepatorenal antioxidant effects of combined oral administration of ammonium metavanadate (AMV; 0.15 mg V/ml) and nickel sulfate (NS; 0.18 mg Ni/ml) in male albino rats over a 21-day period have been evaluated. After administration of vanadium, lipid peroxidation (LPO) increased significantly (p 0.05) in liver, superoxide dismutase (SOD) and glutathione –S-transferase (GST) activities increased significantly in kidney (p < 0.01) and decreased in liver (p < 0.001) whereas glutathione (GSH) content decreased (p < 0.001) in both organs. The exposure to nickel led to a significant decrease (p < 0.001) in SOD, GST activities in liver and GSH content in kidney and a significant (p < 0.001) increase in the hepatic MDA content and renal SOD activity. When the metals were administered in combination, the elevation of lipid peroxidation did not potentiate. However, the inhibition in hepatic SOD was augmented. In the other hand, the combined metals treatment slightly improved the decreased hepatic GST activity and induced the hepatorenal content of GSH. Signs of toxicity were observed following treatment with vanadium, not nickel nor combined vanadium and nickel. A reduction in cellular enzymatic (SOD) and non-enzymatic (GSH) antioxidants is clearly indicative of oxidative stress. The results of this study indicate that kidney is more vulnerable to the caused by vanadium and/or nickel-induced oxidative stress than liver, the oxidative capacity of nickel is much lower than vanadium as well as that the oxidative capacity of combined vanadium and nickel may be more markedly decreased than at separate exposure.
机译:在这项研究中,已评估了在21天的时间内,口服口服偏钒酸铵(AMV; 0.15 mg V / ml)和硫酸镍(NS; 0.18 mg Ni / ml)对肝肾的抗氧化作用。服用钒后,肝脏中的脂质过氧化(LPO)显着增加(p 0.05),肾脏中的超氧化物歧化酶(SOD)和谷胱甘肽-S-转移酶(GST)活性显着增加(p <0.01),而肝脏则下降(p < 0.001),而两个器官中的谷胱甘肽(GSH)含量均下降(p <0.001)。镍暴露导致肝脏中的SOD,GST活性和肾脏中的GSH含量显着下降(p <0.001),肝MDA含量和肾脏SOD活性显着(p <0.001)增加。当金属组合使用时,脂质过氧化的升高没有增强。但是,对肝脏SOD的抑制作用增强了。另一方面,联合金属处理略微改善了肝脏GST活性的下降,并诱导了GSH的肝肾含量。用钒(不是镍,也没有钒和镍的混合物)处理后观察到毒性迹象。细胞酶抗氧化剂(SOD)和非酶抗氧化剂(GSH)的减少清楚地表明了氧化应激。这项研究的结果表明,与肝脏相比,肾脏更容易受到钒和/或镍诱导的氧化应激的影响,镍的氧化能力远低于钒,并且钒和镍的结合物的氧化能力可能比肝脏低。比单独暴露更明显地减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号